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Temporal Response of Rabbits to 6-Adrenergic Agonist Feeding: 
Tissue Weight, Calpains and Calpastatin Activities, and 
Nucleic Acid and Protein Concentrations112 
T. D. Pringle*, S. M. Lonergan*, C. R. Calkins*, S. J. Jones*, 
P. S. Miller*, and M. Koohmaraiet 
*Department of Animal Science, University of Nebraska, Lincoln 68583-0908 and 
?Roman L. Hruska U.S. Meat Animal Research Center, ARS, USDA, Clay Center, NE 68933-0166 
ABSTRACT: Forty-eight crossbred rabbits were 
used in three replications of a 2 x 4 factorial 
arrangement to investigate the short-term responses 
of tissue accretion, calpains and calpastatin activity, 
and nucleic acid and protein concentrations to 6- 
adrenergic agonist (BAA) feeding. Rabbits were fed a 
17% CP diet with or without 7 ppm of L644,969 and 
slaughtered after 1, 4, 8, or 16 d of treatment. Empty 
body dressing percentage and biceps femoris weight 
( a s  a percentage of empty body weight [EBWI) were 
significantly higher in the treated rabbits than in the 
controls after 16 d of treatment. Heart and liver 
weights ( a s  a percentage of EBW) were higher ( P < 
.05) after 1 d and liver weight ( a s  a percentage of 
EBW) was lower ( P  < .05) after 16 d in treated vs 
controls. Except for an elevation of skeletal muscle m- 
calpain after 16 d, BAA-supplementation did not affect 
the calpain-calpastatin system. Muscle RNA concen- 
trations and RNA:DNA ratios were higher ( P  < . 05 )  in 
treated rabbits after 1 d and remained higher 
thereafter. Protein:RNA ratios were lower ( P < .0 1) in 
treated than in control rabbits after 4 d and remained 
lower throughout the trial. Muscle DNA content was 
lower after 4 d and higher after 16 d; RNA content 
was higher after 4, 8, and 16 d; and protein content 
was higher after 16 d in treated vs control rabbits. 
Liver nucleic acid and protein concentrations were not 
affected by BAA treatment. Heart RNA:DNA ratios 
were higher ( P < .0 1) after 1 d and protein:RNA 
ratios were lower ( P  < .05) after 4 d in the treated 
rabbits than in the controls. Collectively, these data 
imply that BAA-induced muscle growth in rabbits 
occurs through hyperplasia and seems to be related to 
elevated protein synthetic capacity. 
Key Words: Rabbits, P-Adrenergic Agonist, Muscle, Liver, Heart, Calpain 
Introduction 
0-Adrenergic agonists ( BAA) are adrenomimetic 
compounds known to increase muscle growth under a 
variety of physiological conditions (for reviews see 
Mersmann, 1989; Yang and McElligott, 1989; Ander- 
son et al., 1991). These compounds also affect other 
organs. Heart weight is increased in rats (Reeds et al., 
1986) and rabbits (Forsberg et al., 1989), decreased 
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in sheep (Kim et al., 1987) and cattle (Moloney et al., 
1990), and remains unchanged in swine (Cromwell et 
al., 1988) treated with BAA. Conversely, liver weight 
is generally decreased by chronic BAA treatment 
(Reeds et al., 1986; Williams et al., 1989; Moloney et 
al., 1990; Muramatsu et al., 1991). 
The mechanism for BAA-induced muscle growth 
has been studied extensively and may vary depending 
on the compound and species studied. The BAA- 
response in skeletal muscle growth has been partially 
attributed to decreased protein degradation (Reeds et 
al., 1986; Bohorov et al., 1987; Bardsley et al., 1992; 
Wheeler and Koohmaraie, 1992). This decrease seems 
to be related to alterations in the calpain proteinase 
system, particularly through elevation of calpastatin 
activity (Kretchmar et al., 1989; Koohmaraie et  al., 
1991; Bardsley et al., 1992; Wheeler and Koohmaraie, 
1992; Pringle et al., 1993). This elevation occurs 
within 2 wk of treatment in lambs and is maintained 
with subsequent treatment (Pringle et al., 1993). 
Because the calpain system is found in both cardiac 
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and hepatic tissues (Murachi et al., 1981), it is 
possible that the BAA-response of these tissues occurs 
through a mechanism similar to that in skeletal 
muscle. Therefore, this experiment was designed to 
investigate the mechanism(s1 for the short-term 
responses of rabbit skeletal muscle, heart, and liver to 
BAA treatment. 
Experimental Procedures 
Experimental Design. Forty-eight doe rabbits (New 
Zealand White x California White; Elmwood Rabbit 
Production, Elmwood, NE) were assigned to three 
replicates of a 2 x 4 factorial arrangement, with two 
treatments (control and treated) and four slaughter 
end points (1,  4, 8, and 16 d). In addition, two rabbits 
were slaughtered a t  the initiation of each replicate to 
establish baseline values for the variables measured 
( n  = 6).  All housing, handling, and experimental 
procedures were approved by the University of 
Nebraska-Lincoln Institutional Animal Care and Use 
Committee. Upon delivery, the rabbits were ranked by 
weight, divided into groups of nine (including the 
initial slaughter group), and assigned to the nine 
treatments. The rabbits were individually housed and 
conditioned to their diets and surroundings for 10 to 
14 d before initiation of each replicate, receiving ad 
libitum access to feed3 and water containing 1.3% 
(vol/vol) of a coccidiostat (Albon; Roche, Nutley, NJ).  
The control rabbits had ad libitum access to water 
and feed, along with 5 g of molasses, top-dressed daily 
on the diet. The treated rabbits received the same diet 
with the equivalent of 7 ppm of the P-adrenergic 
agonist L644,969 added to the molasses. The rabbits 
were weighed on two consecutive days to start each 
replicate and once a t  assigned slaughter times ( 1 ,  4 ,8,  
and 16 d). After weighing, the rabbits assigned to that 
slaughter end point were lightly anaesthetized with 
COz and killed by decapitation. Blood was collected for 
determination of urea nitrogen. Within 30 min post- 
mortem, a randomly selected hindlimb of each rabbit 
was skinned and the biceps femoris muscle was 
removed intact and weighed. The abdominal and 
thoracic cavities were opened and the liver and heart 
were removed and weighed. After weighing, tissues 
were minced and sampled fresh ( 5  g)  for determina- 
tion of calpains and calpastatin activities. The re- 
mainder of the tissue was frozen at -70°C and stored 
for measurement of nucleic acid and protein concen- 
trations. Because of small size, hearts were pooled for 
the two rabbits in each treatment at  each slaughter 
end point, before sampling. Because the rabbits had 
access to feed and water immediately before slaughter, 
3~urina '  Rabbit chow' Performance Blend, a pelleted feed 
containing > 17.0% CP, 2.0% crude fat, 18.0% crude fiber, and 8.0% 
ash. 
empty body weight ( EBW) was measured to minimize 
the variation caused by gastrointestinal fill. After 
tissue sampling, each full gastrointestinal tract was 
weighed, emptied, blotted dry, and reweighed. Empty 
body weight included the empty gastrointestinal tract. 
Within 10 h postmortem, carcasses were skinned, 
washed, weighed, and stored at -20°C. 
Determination of Calpain and Calpastatin Activity. 
Activities of the calpains and calpastatin were deter- 
mined on unfrozen, prerigor skeletal muscle, heart, 
and liver samples according to the procedures of 
Koohmaraie (1990) with the following modifications. 
Tissue samples ( 5  g )  were homogenized in 2.5 
volumes of extraction buffer (100 mM Tris, 5 mM 
EDTA, and 10 rnM 0-mercaptoethanol [MCEI, pH 
8.3), centrifuged, filtered, and dialyzed overnight 
(molecular weight cutoff 12,000 to 14,000) in buffer 
(20 mM Tris, 5 rnM EDTA, and 10 mM 0-MCE, pH 
7.5). The dialyzed samples were centrifuged, filtered, 
loaded onto anion exchange (DEAE-Sephacel; Sigma 
Chemical, St. Louis, MO) columns (1.5 cm x 20 cm; 
Bio-Rad, Richmond, CA), and washed with three to 
five column volumes of elution buffer (20 mM Tris, .l 
mM EDTA, and 10 mM 0-MCE, pH 7.35). The 
samples were eluted using a linear NaCl gradient in 
elution buffer ( 0  to 350 mM, total volume 500 mL for 
skeletal muscle; and 0 to 400 mM, total volume 400 
mL for heart and liver). For skeletal muscle 150 
fractions ( 3  mL) and for heart and liver 130 fractions 
( 3  mL) were collected. 
Activities of skeletal muscle p- and m-calpain and 
heart and liver m-calpain were determined using a 
casein solution (100 rnM Tris, 1 mM NaN3, 5 mM 
CaC12, 2 &/mL of P-MCE, and 5 mg/mL casein, pH 
7.5). One unit of proteinase activity was defined as 
the amount of enzyme necessary to cause an increase 
of 1.0 absorbance unit at  278 nm. Skeletal muscle 
calpastatin activity was determined using the same 
casein solution, following the procedures of Kooh- 
maraie (1990). Because of the abundance of calpasta- 
tin in heart and liver samples, calpastatin and p- 
calpain could not be adequately separated. Therefore, 
calpastatin activity was measured using the procedure 
of Koohmaraie et al. ( 1987). An aliquot ( 2  mL) from 
fractions thought to contain calpastatin was heated at 
90°C for 4 min and centrifuged (2,000 x g )  to 
precipitate the denatured material. The supernatant 
volume was recorded and the samples were assayed 
for calpastatin as described above with adjustment of 
calpastatin activity for changes in volume due to 
heating. One unit of inhibitor activity was defined as 
the amount of calpastatin necessary to inhibit one unit 
of DEAE-purified rabbit lung m-calpain activity. The 
various components of the calpain-calpastatin system 
eluted from our columns in a manner consistent with 
that reported by Wheeler and Koohmaraie (1991). 
Nucleic Acid and Protein Concentrations. Tissue 
DNA was determined using the fluorogenic intercalat- 
ing agent Hoechst 33258 (Sigma Chemical, St. Louis, 
MO; Labarca and Paigen, 1980). Tissue RNA was 
measured spectrophotometrically using the procedures 
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of Munro and Fleck ( 1969), and tissue protein was 
determined using the biuret procedure of Gornall et al. 
(1949). Nucleic acid and protein contents of the 
tissues were calculated by multiplying the various 
concentrations in the tissues by the weights of the 
tissues. 
Blood Urea Nitrogen. Blood was allowed to sit 
overnight at  4"C, centrifuged (2,500 x g) for 10 min, 
and the serum collected and frozen at -20°C for future 
analysis. Blood urea nitrogen was determined accord- 
ing to the procedures of Crocker (19671, using a 
Sigma urea nitrogen kit (Sigma Chemical; procedure 
#535). 
Statistical Analyses. The data were analyzed using 
ANOVA for a completely randomized design with 
replication (Steel and Torrie, 1980). The treatment 
means of treated and control rabbits at  specific 
slaughter end points, along with linear and quadratic 
effects, were compared with single df contrasts using 
the interaction of treatment and replication as the 
error term. The data are presented as means f SEM. 
Different values for SE within a trait are due to 
differences in the number of observations for means. 
Results 
Animal Performance and Tissue Weights. Average 
daily gain was not affected ( P > .5) by BAA treatment 
during the trial (Table 1) .  Empty body weight (Table 
1) was higher in the control than in the BAA-fed 
rabbits after 4 d but was similar thereafter. Dressing 
percentage and biceps femoris weight ( a s  a percentage 
of EBW, Table 1 and wet weight, data not shown) 
increased linearly in the BAA-fed rabbits and were 
higher than those in controls ( P  < .05) after 16 d. 
Liver weight ( a s  a percentage of EBW; Table 1) 
increased initially and decreased thereafter in the 
BAA group and was higher after 1 d ( P  < .05) and 
lower after 16 d ( P < .05) in the treated rabbits than 
in the controls. Heart weight ( a s  a percentage of 
EBW; Table 1 ) was higher in the treated rabbits after 
1 d ( P  < .01) and returned to control values 
thereafter. Blood urea nitrogen was numerically lower 
in the treated rabbits after 1 d and remained lower 
throughout the study. However, these differences were 
not significant ( P  > .20; Table 1). 
Calpain-Calpastatin System. Except for the activity 
of skeletal muscle m-calpain, the calpain-calpastatin 
system was not affected ( P  > .20) by dietary BAA 
administration in the three tissues investigated (Ta- 
ble 2). Skeletal muscle m-calpain activity tended to be 
lower ( P  < . l o )  after 1 d and was higher ( P  < .05) 
after 16 d of BAA treatment. The ratios of the two 
proteinases and pr0teinase:inhibitor activities in mus- 
cle are consistent with other data in rabbits 
(Gopalakrishna and Barsky, 1985). The data for the 
various tissues are also comparable with earlier 
findings (Gopalakrishna and Barsky, 1985; Blomgren 
et al., 1989). 
Table 1. Response of final empty body weight, average daily gain, dressing percentage, 
and tissue weights to 0-adrenergic agonist (BAA] treatment 
Time on feed, d 
Trait 0 1 4 8 16 
Empty body wt (EBW), g 
Controla 1,642.0 + 47.3 1,804.7 i 47.3 1,851.1 f 47.3* 1,938.4 i 47.3 2,182.1 f 41.7 
 BAA^,^ 1,642.0 + 47.3 1,692.0 k 47.3 1,692.0 + 47.3 1,938.7 i 47.3 2,196.1 f 39.1 
ADG, g 
ControlC - 82.4 F 13.5 26.9 f 13.5 27.6 f 13.5 29.5 k 12.7 
BAA - 60.4 i 13.5 31.1 + 13.5 39.0 + 13.5 33.1 f 11.9 
EBW dressing percentage, 4 
Control 58.7 + .9 57.6 F .9 59.5 f .9 57.2 i .9 58.5 f .8* 
BAAC 58.7 f .9 57.3 i .9 58.7 + .9 58.6 i .9 61.2 f .8 
Biceps femoris wt, 5% of EBW 
Control 1.49 If- .03 1.44 i .03 1.51 + .03 1.49 i .03 1.50 f .03"* 
~-4.4~" 1.49 + .03 1.43 F .03 1.50 + .03 1.55 i .03 1.74 + .03 
Liver wt, '36 of EBW 
Control 3.96 + .27 3.50 i .27* 3.66 + .27 3.53 i .27 4.15 f .24* 
BAAC 3.96 + .27 4.53 i .27 3.44 + .27 3.37 i .27 3.39 f .22 
Heart wt, % of EBW 
Control .28 f . O 1  .26 F .01** .28 + .O1 .26 i .01 .26 + .01 
BAA .28 + .01 3 1  + .01 .28 + .01 .27 i .01 .27 f .O1 
Blood urea nitrogen, mg/dL 
Control 19.4 f 1.7 18.3 i 1.7 17.2 f 1.7 21.6 F 1.7 19.3 + 1.5 
BAA 19.4 + 1.7 15.2 i 1.7 16.4 + 1.7 19.2 i 1.7 15.9 i 1.4 
aLinear effect ( P  < .01). 
b ~ u a d r a t i c  effect ( P  < .01). 
'Linear effect ( P  < .05). 
****Means within a trait, a t  a specific time, differ ( P  < .05 and .0l, respectively). 
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Table 2. Response of biceps femoris (BF), liver, and heart calpains and calpastatin 
activities to 0-adrenergic agonist (BAA] treatment 
Time on feed, d 
Trait 0 1 4 8 16 
BF pcalpain, units/ga 
Control .53 f .08 .53 f .08 .41 f .08 .42 f .08 .52 f .08 
BAA .53 f .08 .39 f .08 .31 f .08 .42 f .08 .46 f .08 
BF m-calpain, units/g 
Control 1.09 i .10 1.15 f .lo' 1.01 f .10 . 9 6 f  .10 1.03 f .lo* 
 BAA^ 1.09 + .10 .88 f .10 1.15 f .10 1.19 f .10 1 .38 f  .10 
BF calpastatin, units/$' 
Control 4.74 f .60 4.14 f .60 4.04 f .60 4.12 + .60 4.46 f .60 
BAA 4.74 f .60 4.67 f .60 5.32 f .60 3.21 + .70 3.75 f .60 
Liver calpastatin, units/$' 
Control 8.37 f .60 6.59 f .60 6.60 + .60 6.95 f .60 6.46 f .60 
BAA 8.37 + .60 7.23 f .60 7.78 f .60 6.25 f .60 6.38 f .60 
Heart calpastatin, units/ga 
Control 9.46 f 1.12 9.26 f 1.12 9.96 + 1.12 9.78 f 1.12 10.53 f 1.12 
BAA 9.46 f 1.12 11.08 f 1.12 9.71 f 1.41 10.48 + 1.12 12.41 F 1.12 
aNo treatment effect (P > .2). 
b ~ i n e a r  effect ( P  < .01). 
t , * ~ e a n s  within a trait, a t  a specific time, differ ( P  < .10 and .05, respectively). 
Nucleic Acids and Protein. Biceps femoris DNA and 
protein concentrations and protein:DNA ratios were 
not affected by BAA treatment ( P  > .5; data not 
shown). The RNA concentration and RNA:DNA ratio 
were higher in the BAA-fed rabbits than in controls 
after 1 d and remained higher throughout the feeding 
period (Table 3). The difference between treated and 
control rabbits increased to 4 d and then attenuated 
with continued BAA administration. Conversely, the 
muscle protein:RNA ratio (Table 3 )  in the BAA-fed 
rabbits was lower after 4, 8, and 16 d compared with 
controls. Primarily because of the advantage in muscle 
weights, DNA and protein contents were higher in the 
treated rabbit muscle than in the controls after 16 d 
(Table 4). The RNA content of the biceps femoris from 
BAA-treated rabbits was higher than in controls after 
4, 8, and 16 d. 
Unlike skeletal muscle, neither liver nor heart 
nucleic acid and protein concentrations were affected 
( P  > .20) by BAA treatment (data not shown). Heart 
protein:DNA ratio was higher after 1 d ( P  < .05); 
RNA:DNA ratio was higher after 1 ( P < .0 1) and 4 d 
( P  < . lo) ;  and protein:RNA ratio was lower after 4 d 
( P  < .05). All ratios were similar to controls within 8 d 
of treatment initiation (Table 3). Although liver 
protein content was not affected by BAA treatment ( P  
> .5), both liver DNA and RNA contents were higher 
in the treated rabbits a t  the conclusion of the study. 
Discussion 
One of the most consistent responses to BAA 
treatment is enhanced muscle growth (Yang and 
McElligott, 1989), most prominently in muscles domi- 
nated by Type I1 (fast-twitch, glycolytic) fibers 
(Beermann et al., 1987). In our study, BAA-treated 
muscle weight began to diverge from controls after 8 d 
and was significantly higher than controls after 16 d 
of treatment. 
It  is commonly postulated that BAA-induced muscle 
growth occurs through a hypertrophic model (Beer- 
mann et al., 1987; Kim et al., 1987; Kretchmar et al., 
1989; Koohmaraie et al., 1991; Pringle et al., 1993). 
This does not seem to be the case in rabbits. Forsberg 
et al. (1989) reported that DNA content was in- 
creased in the biceps femoris, extensor digitorium 
longus, and gastrocnemius muscles of cimaterol- 
treated rabbits and suggested a mechanism involving 
satellite cell incorporation to explain the changes in 
muscle growth. 0-Adrenergic agonist treatment has 
also increased DNA in transplanted (Roberts and 
McGeachie, 1992) and denervated (Maltin et al., 
1989) mouse muscle and caused increased prolifera- 
tion of cultured chick embryo breast muscle satellite 
cells (Grant et al., 1990). However, further investiga- 
tion of BAA-treated, denervated muscle showed no 
increase in DNA, recruitment of satellite cells, or 
mitosis (Maltin and Delday, 1992). These researchers 
suggested that the increases in DNA content of BAA- 
treated muscle may be due to proliferation of non- 
myofiber cells, as shown by Dumont et al. (1989). 
Unfortunately, our procedures for measuring DNA do 
not allow separation of myofiber from non-myofiber 
DNA. Thus, although biceps femoris DNA content was 
increased after 16 d of BAA treatment in this study, it 
is not obvious whether these changes were truly 
indicative of hyperplastic growth. 
Previous work in lambs (Kretchmar et al., 1989; 
Koohmaraie et al., 1991; Pringle et al., 1993) and 
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Table 3. Response of biceps femoris (BF) and heart RNA concentration and RNA:DNA 
and protein:RNA ratios to 0-adrenergic agonist (BAA) treatment 
Time on feed. d 
Trait 0 1 4 8 16 
BF RNA concentration, pg/g 
Control 
 BAA^^ 
BF RNA:DNA, pglpg 
Control 
BAA~C 
BF protein:RNA, mglmg 
Control 
B A A ~ c  
Heart RNA concentration, mglgd 
Control 
BAA 
Heart protein:DNA, mdmg 
ControlC 
BAA 
Heart RNA:DNA, mg/mg 
Control 
BAAe 
Heart protein:RNA, mglmg 
Control 
BAA 
aLinear effect ( P  < ,011. 
b ~ u a d r a t i c  effect ( P < ,011. 
CLinear effect ( P  < .05). 
d ~ o  treatment effect ( P  > ,351. 
eQuadratic effect ( P  < .05). 
?,*,**Means within a trait, a t  a specific time, differ ( P  < .05 and .01, respectively) 
Table 4. Response of biceps femoris (BF) and liver total nucleic acid and protein 
contents to a 0-adrenergic agonist (BAA) treatment 
Time on feed, d 
Trait 0 1 4 8 16 
BF DNA, mg 
Controla 
 BAA^^ 
BF RNA, mg 
ControlC 
BAAa 
BF protein, g 
Controla 
 BAA^^ 
Liver DNA, mg 
Control 
 BAA^^ 
Liver RNA, mg 
ControlC 
 BAA^ 
Liver protein, g 
Controla 
BAAa 
aLinear effect ( P  < .01). 
b ~ u a d r a t i c  effect ( P  < .01). 
'Linear effect ( P  < ,051. 
d ~ u a d r a t i c  effect ( P  < .05). 
+,*-**Means within a trait, a t  a specific time, differ ( P  < .lo, .05, and .01, respectively). 
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cattle (Wheeler and Koohmaraie, 1992) demonstrated (Kim et al., 1987; Williams et al., 1989) and cattle 
a positive relationship between BAA-induced muscle (Moloney et al., 1990), and similar weights in swine 
growth and calpastatin activity. The majority of the (Cromwell et al., 1988). In our study, heart weight 
BAA-induced alterations in lamb muscle weight and was higher after 1 d of BAA treatment and not 
calpastatin activity occurs within 2 wk of treatment different from controls thereafter. The change in 
initiation (Pringle et al., 1993). Our data suggest that weight was again independent of significant change in 
the enhanced muscle growth of BAA-treated rabbits the calpain-calpastatin system. The increase in weight 
does not require alteration of the calpain-calpastatin Was accompanied by an increase in cell mass (protein: 
system. The only change in the calpain-calpastatin DNA; Table 31, indicative of hypertrophic growth in 
system was an increase in the activity of m-calpain, BAA-treated cardiac muscle. Heart RNA:DNA ratios 
which is consistent with other reports (Kretchmar et were also significantly higher after 1 d of treatment, 
al., 1989; ~ ~ ~ h ~ ~ ~ ~ i ~  et al., 1991). H ~ ~ ~ ~ ~ ,  it is suggesting that an increase in the protein transcrip- 
difficult to conceive how this change could cause the tional efficiency and synthetic capacity of cardiac 
increased muscle growth noted in this study. In tissue may account for the slight changes in weight. 
agreement with the calpain-calpastatin findings, our Commonly, chronic BAA treatment has decreased liver weight (Reeds et al., 1986; Kim et al., 1987; 
urea data suggest that the Williams et al., 1989; Maloney et al., 1990; 
proteolytic rabbit is Muramatsu et al., 1991). Our data agree, except hat 
unchanged BAA treatment. The and P-  liver weight in the BAA-treated rabbits increased 
ca l~ain  data in this study do not agree with the after 1 d of treatment (Table 1) .  According to the 
findings of ~orsberg  et al. (1989), who fed BAA to hypothesis, in muscle, that calpastatin activity is 
rabbits for a prolonged period. researchers related to tissue size, then calpastatin activity in liver 
reported that cimaterol treatment decreased the should decrease after 16 d of BAA treatment. H ~ ~ -  
activity of skeletal muscle calpastatin and pcalpain. ever, in this study there were no BAA-induced 
These discrepancies may be partially due to differ- responses in either liver m-calpain or calpastatin 
ences in the length of BAA treatment. Their data must activities or in the concentrations of nucleic acids or 
also be interpreted with caution, because frozen protein, suggesting the lack of a clear relationship 
samples were used to measure the calpain-calpastatin between any of the variables measured and liver size 
system and Koohmaraie (1990), Sainz et al. (1992), in BAA-fed rabbits. The changes in liver weight may 
and Whipple and Koohmaraie (1992) have since simply be a reflection of the changes in tissue blood 
reported that freezing of skeletal muscle decreased flow that accompany BAA supplementation. Eisemann 
calpastatin and pcalpain activities. et al. (1988) reported that heart rate and blood flow 
The BAA-induced increase in RNA concentration Were increased by acute BAA treatment, whereas 
and content and RNA:DNA ratio are consistent with chronic treatment shunted blood flow to the muscula- 
results of previous studies (Beermann et al., 1987; ture of the animal. Another possibility for the 
Forsberg et al., 1989; Williams et al., 1989; Kooh- decreased liver weights is a decrease in the fractional protein synthesis rates, as reported by Muramatsu et 
maraie et al., 1991; Pringle et al., 1993). Changes in 
al. ( 199 
muscle weight appear after the RNA concentration 
and RNA:DNA ratio begin to attenuate. It  seems that 
the protein synthetic capacity is higher in the BAA- Implications 
treated muscle, but it is unclear why the RNA 
measurements seem to peak before detectible changes A better understanding of the regulation of 
in muscle weight. Collectivel~, these data suggest an muscle, heart,, and liver growth could allow enhanced 
alternative mechanism for BAA-hluced muscle growth eficiency of meat animals through exogenous 
growth in rabbits. The muscle data suggest that BAA- alteration of these tissues. It seems that rabbits fed a 
induced muscle growth in rabbits occurs a t  least 0-adrenergic agonist respond differently than do 
partially through a hyperplastic mechanism, whereby sheep, offering another avenue for study of the 
muscle protein synthetic capacity is elevated. This is processes controlling tissue growth. Although these 
contrary to the strictly hypertrophic mechanism data are not conclusive as to a mechanism for /3- 
reported in sheep and cattle, whereby protein degrada- adrenergic-agonist-induced tissue growth in rabbits, 
tion is generally lowered, and concurs with the they offer direction for future considerations into the 
ruminant-specific effect of BAA-supplementation men- study of the mechanism of action of 0-adrenergic 
tioned by Bardsley et al. (1992). agonists. 
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